{"transactions":[{"id":719966,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":33476,"kind":"person","name":"Alland Leila","position":1,"cik":"0001825216","reported_name":"Alland Leila","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-02T20:30:24.000Z","date":"2026-06-30","kind":"sale","planned":false,"acquired":false,"shares":11000,"price":5.917,"value":65087.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.915 to $5.9334 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":162614,"source":{"system":"sec-edgar","filing":"0001493152-26-031906","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315226031906/ownership.xml","form_type":"4"}},{"id":926175,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":33476,"kind":"person","name":"Alland Leila","position":1,"cik":"0001825216","reported_name":"Alland Leila","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-02T21:30:02.000Z","date":"2026-02-02","kind":"sale","planned":false,"acquired":false,"shares":18065,"price":5.0906,"value":91961.689,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was to cover tax obligations associated with the vesting of restricted stock awards."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.09 to $5.12 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":173614,"source":{"system":"sec-edgar","filing":"0001493152-26-004761","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315226004761/ownership.xml","form_type":"4"}},{"id":930625,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":33476,"kind":"person","name":"Alland Leila","position":1,"cik":"0001825216","reported_name":"Alland Leila","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-27T21:30:18.000Z","date":"2026-01-26","kind":"grant","planned":false,"acquired":true,"shares":37313,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"All of the restricted stock will vest on January 26, 2027."}],"balance_after":191679,"source":{"system":"sec-edgar","filing":"0001493152-26-003803","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315226003803/ownership.xml","form_type":"4"}},{"id":1288474,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":33476,"kind":"person","name":"Alland Leila","position":1,"cik":"0001825216","reported_name":"Alland Leila","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-02-04T01:37:36.000Z","date":"2025-01-31","kind":"grant","planned":false,"acquired":true,"shares":36101,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Upon vesting, a portion of the restricted stock may be surrendered to satisfy the reporting person's tax withholding obligation. Any deemed disposition of the withheld shares would be exempt pursuant to Rule 16b-3(e)."},{"field":"shares","element":"transactionShares","label":"F2","text":"All of the restricted stock will vest on January 31, 2026."}],"balance_after":154366,"source":{"system":"sec-edgar","filing":"0001493152-25-004748","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315225004748/ownership.xml","form_type":"4"}},{"id":1422643,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":33476,"kind":"person","name":"Alland Leila","position":1,"cik":"0001825216","reported_name":"Alland Leila","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-27T23:05:19.000Z","date":"2024-08-26","kind":"grant","planned":false,"acquired":true,"shares":11797,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The acquisition was exempt pursuant to Rule 16b-3(d)."},{"field":"shares","element":"transactionShares","label":"F2","text":"This stock grant represents the remainder of the 2024 annual grant to board of directors. This portion of the annual stock grant was withheld until all employees/management were allocated their shares and in order to enable onboarding of two new Board members. All of the restricted stock will vest on August 26, 2025."}],"balance_after":118265,"source":{"system":"sec-edgar","filing":"0001493152-24-034048","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315224034048/ownership.xml","form_type":"4"}},{"id":1458005,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":33476,"kind":"person","name":"Alland Leila","position":1,"cik":"0001825216","reported_name":"Alland Leila","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-07-09T20:35:33.000Z","date":"2024-07-08","kind":"grant","planned":false,"acquired":true,"shares":23611,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"All of the restricted stock will vest on July 8, 2025."}],"balance_after":106468,"source":{"system":"sec-edgar","filing":"0001493152-24-026643","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315224026643/ownership.xml","form_type":"4"}},{"id":1509853,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":33476,"kind":"person","name":"Alland Leila","position":1,"cik":"0001825216","reported_name":"Alland Leila","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-20T12:30:14.000Z","date":"2024-05-16","kind":"purchase","planned":false,"acquired":true,"shares":11000,"price":4.709,"value":51799.0,"ownership":{"direct":true},"balance_after":82857,"source":{"system":"sec-edgar","filing":"0001493152-24-020542","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315224020542/ownership.xml","form_type":"4"}},{"id":1771877,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":33476,"kind":"person","name":"Alland Leila","position":1,"cik":"0001825216","reported_name":"Alland Leila","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-09-29T20:30:17.000Z","date":"2023-09-27","kind":"sale","planned":false,"acquired":false,"shares":7246,"price":3.9014,"value":28269.5444,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was to cover tax obligations associated with vesting of restricted stock awards."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Weighted average price. These shares were sold in multiple transactions at prices ranging from $3.8200 to $4.2000 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":71857,"source":{"system":"sec-edgar","filing":"0001493152-23-034854","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315223034854/ownership.xml","form_type":"4"}},{"id":1778615,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":33476,"kind":"person","name":"Alland Leila","position":1,"cik":"0001825216","reported_name":"Alland Leila","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-09-18T20:22:58.000Z","date":"2023-09-15","kind":"sale","planned":false,"acquired":false,"shares":6291,"price":6.62,"value":41646.42,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units, or RSUs."}],"balance_after":45909,"source":{"system":"sec-edgar","filing":"0001209191-23-049751","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1699382/000120919123049751/doc4.xml","form_type":"4"}},{"id":1853507,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":33476,"kind":"person","name":"Alland Leila","position":1,"cik":"0001825216","reported_name":"Alland Leila","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-16T20:05:20.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":58689,"price":4.62,"value":271143.18,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"All of the restricted stock will vest on June 14, 2024."}],"balance_after":79103,"source":{"system":"sec-edgar","filing":"0001493152-23-021651","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315223021651/ownership.xml","form_type":"4"}},{"id":1893005,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":33476,"kind":"person","name":"Alland Leila","position":1,"cik":"0001825216","reported_name":"Alland Leila","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-05-15T22:14:08.000Z","date":"2023-05-12","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to the option vest in 48 equal monthly installments beginning on June 12, 2023."}],"balance_after":100000,"derivative":{"exercise_price":5.7,"expiration_date":"2033-05-12","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001209191-23-029609","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1699382/000120919123029609/doc4.xml","form_type":"4"}},{"id":2150200,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":33476,"kind":"person","name":"Alland Leila","position":1,"cik":"0001825216","reported_name":"Alland Leila","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-09-28T20:39:05.000Z","date":"2022-09-26","kind":"grant","acquired":true,"shares":13400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"All of the restricted stock will vest on September 26, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On July 1, 2022, the issuer effectuated a 1-for-25 reverse stock split."}],"balance_after":20414,"source":{"system":"sec-edgar","filing":"0001493152-22-027052","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315222027052/ownership.xml","form_type":"4"}},{"id":2159865,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":33476,"kind":"person","name":"Alland Leila","position":1,"cik":"0001825216","reported_name":"Alland Leila","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-09-13T20:23:15.000Z","date":"2022-09-09","kind":"grant","acquired":true,"shares":52200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported shares are represented by restricted stock units, or RSUS. One- third of the RSUs vest on September 9, 2023 and the remaining shares vest on September 9, 2024."}],"balance_after":52200,"source":{"system":"sec-edgar","filing":"0001209191-22-049692","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1699382/000120919122049692/doc4.xml","form_type":"4"}},{"id":2368277,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":33476,"kind":"person","name":"Alland Leila","position":1,"cik":"0001825216","reported_name":"Alland Leila","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-02-28T21:25:12.000Z","date":"2022-02-10","kind":"grant","acquired":true,"shares":104400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to the option vest in 48 equal monthly installments beginning on March 10, 2022."}],"balance_after":104400,"derivative":{"exercise_price":16.29,"expiration_date":"2032-02-10","underlying":"Common Stock","underlying_shares":104400},"source":{"system":"sec-edgar","filing":"0001209191-22-013569","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1699382/000120919122013569/doc4.xml","form_type":"4"}},{"id":2572858,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":33476,"kind":"person","name":"Alland Leila","position":1,"cik":"0001825216","reported_name":"Alland Leila","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-09-10T20:14:56.000Z","date":"2021-09-09","kind":"exercise","acquired":false,"shares":100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-fourth of the shares subject to the option vested on December 3, 2020, and one forty-eighth of the shares subject to the option shall vest each month thereafter."}],"balance_after":353850,"derivative":{"exercise_price":3.9,"expiration_date":"2030-02-04","underlying":"Common Stock","underlying_shares":100},"source":{"system":"sec-edgar","filing":"0001209191-21-055438","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1699382/000120919121055438/doc4.xml","form_type":"4"}},{"id":2572857,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":33476,"kind":"person","name":"Alland Leila","position":1,"cik":"0001825216","reported_name":"Alland Leila","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-09-10T20:14:56.000Z","date":"2021-09-09","kind":"sale","acquired":false,"shares":100,"price":30.25,"value":3025.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 30, 2020."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-21-055438","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1699382/000120919121055438/doc4.xml","form_type":"4"}},{"id":2572856,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":33476,"kind":"person","name":"Alland Leila","position":1,"cik":"0001825216","reported_name":"Alland Leila","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-09-10T20:14:56.000Z","date":"2021-09-09","kind":"exercise","acquired":true,"shares":100,"price":3.9,"value":390.0,"ownership":{"direct":true},"balance_after":100,"source":{"system":"sec-edgar","filing":"0001209191-21-055438","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1699382/000120919121055438/doc4.xml","form_type":"4"}},{"id":2575567,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":33476,"kind":"person","name":"Alland Leila","position":1,"cik":"0001825216","reported_name":"Alland Leila","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-09-08T20:22:43.000Z","date":"2021-09-07","kind":"exercise","acquired":false,"shares":3900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-fourth of the shares subject to the option vested on December 3, 2020, and one forty-eighth of the shares subject to the option shall vest each month thereafter."}],"balance_after":353950,"derivative":{"exercise_price":3.9,"expiration_date":"2030-02-04","underlying":"Common Stock","underlying_shares":3900},"source":{"system":"sec-edgar","filing":"0001209191-21-055140","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1699382/000120919121055140/doc4.xml","form_type":"4"}},{"id":2575566,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":33476,"kind":"person","name":"Alland Leila","position":1,"cik":"0001825216","reported_name":"Alland Leila","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-09-08T20:22:43.000Z","date":"2021-09-07","kind":"sale","acquired":false,"shares":3900,"price":30.25,"value":117975.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 30, 2020."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-21-055140","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1699382/000120919121055140/doc4.xml","form_type":"4"}},{"id":2575565,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":33476,"kind":"person","name":"Alland Leila","position":1,"cik":"0001825216","reported_name":"Alland Leila","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-09-08T20:22:43.000Z","date":"2021-09-07","kind":"exercise","acquired":true,"shares":3900,"price":3.9,"value":15210.0,"ownership":{"direct":true},"balance_after":3900,"source":{"system":"sec-edgar","filing":"0001209191-21-055140","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1699382/000120919121055140/doc4.xml","form_type":"4"}},{"id":2608059,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":33476,"kind":"person","name":"Alland Leila","position":1,"cik":"0001825216","reported_name":"Alland Leila","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-08-10T22:14:51.000Z","date":"2021-08-09","kind":"exercise","acquired":false,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"One-fourth of the shares subject to the option vested on December 3, 2020, and one forty-eighth of the shares subject to the option shall vest each month thereafter."}],"balance_after":357850,"derivative":{"exercise_price":3.9,"expiration_date":"2030-02-04","underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001209191-21-050670","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1699382/000120919121050670/doc4.xml","form_type":"4"}},{"id":2608058,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":33476,"kind":"person","name":"Alland Leila","position":1,"cik":"0001825216","reported_name":"Alland Leila","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-08-10T22:14:51.000Z","date":"2021-08-09","kind":"sale","acquired":false,"shares":224,"price":36.69,"value":8218.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 30, 2020."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-21-050670","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1699382/000120919121050670/doc4.xml","form_type":"4"}},{"id":2608057,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":33476,"kind":"person","name":"Alland Leila","position":1,"cik":"0001825216","reported_name":"Alland Leila","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-08-10T22:14:51.000Z","date":"2021-08-09","kind":"sale","acquired":false,"shares":2049,"price":32.6567,"value":66913.5783,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 30, 2020."},{"field":"shares","element":"transactionShares","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.605 to $36.50, inclusive."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.605 to $36.50, inclusive."}],"balance_after":224,"source":{"system":"sec-edgar","filing":"0001209191-21-050670","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1699382/000120919121050670/doc4.xml","form_type":"4"}},{"id":2608056,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":33476,"kind":"person","name":"Alland Leila","position":1,"cik":"0001825216","reported_name":"Alland Leila","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-08-10T22:14:51.000Z","date":"2021-08-09","kind":"sale","acquired":false,"shares":2198,"price":35.0637,"value":77070.0126,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 30, 2020."},{"field":"shares","element":"transactionShares","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.575 to $35.39, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.575 to $35.39, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4."}],"balance_after":1802,"source":{"system":"sec-edgar","filing":"0001209191-21-050670","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1699382/000120919121050670/doc4.xml","form_type":"4"}},{"id":2608055,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":33476,"kind":"person","name":"Alland Leila","position":1,"cik":"0001825216","reported_name":"Alland Leila","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-08-10T22:14:51.000Z","date":"2021-08-09","kind":"exercise","acquired":true,"shares":4000,"price":3.9,"value":15600.0,"ownership":{"direct":true},"balance_after":4000,"source":{"system":"sec-edgar","filing":"0001209191-21-050670","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1699382/000120919121050670/doc4.xml","form_type":"4"}},{"id":2637707,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":33476,"kind":"person","name":"Alland Leila","position":1,"cik":"0001825216","reported_name":"Alland Leila","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-07-08T20:10:29.000Z","date":"2021-07-07","kind":"exercise","acquired":false,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"One-fourth of the shares subject to the option vested on December 3, 2020, and one forty-eighth of the shares subject to the option shall vest each month thereafter."}],"balance_after":361850,"derivative":{"exercise_price":3.9,"expiration_date":"2030-02-04","underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001209191-21-045989","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1699382/000120919121045989/doc4.xml","form_type":"4"}},{"id":2637706,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":33476,"kind":"person","name":"Alland Leila","position":1,"cik":"0001825216","reported_name":"Alland Leila","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-07-08T20:10:29.000Z","date":"2021-07-07","kind":"sale","acquired":false,"shares":2049,"price":32.6567,"value":66913.5783,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 30, 2020."},{"field":"shares","element":"transactionShares","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.455 to $32.835, inclusive."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-21-045989","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1699382/000120919121045989/doc4.xml","form_type":"4"}},{"id":2637705,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":33476,"kind":"person","name":"Alland Leila","position":1,"cik":"0001825216","reported_name":"Alland Leila","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-07-08T20:10:29.000Z","date":"2021-07-07","kind":"sale","acquired":false,"shares":1951,"price":31.9321,"value":62299.5271,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 30, 2020."},{"field":"shares","element":"transactionShares","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.455 to $32.40, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4."}],"balance_after":2049,"source":{"system":"sec-edgar","filing":"0001209191-21-045989","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1699382/000120919121045989/doc4.xml","form_type":"4"}},{"id":2637704,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":33476,"kind":"person","name":"Alland Leila","position":1,"cik":"0001825216","reported_name":"Alland Leila","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-07-08T20:10:29.000Z","date":"2021-07-07","kind":"exercise","acquired":true,"shares":4000,"price":3.9,"value":15600.0,"ownership":{"direct":true},"balance_after":4000,"source":{"system":"sec-edgar","filing":"0001209191-21-045989","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1699382/000120919121045989/doc4.xml","form_type":"4"}},{"id":2676943,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":33476,"kind":"person","name":"Alland Leila","position":1,"cik":"0001825216","reported_name":"Alland Leila","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-06-08T23:22:02.000Z","date":"2021-06-07","kind":"exercise","acquired":false,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"One-fourth of the shares subject to the option vested on December 3, 2020, and one forty-eighth of the shares subject to the option shall vest each month thereafter."}],"balance_after":365850,"derivative":{"exercise_price":3.9,"expiration_date":"2030-02-04","underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001209191-21-039035","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1699382/000120919121039035/doc4.xml","form_type":"4"}},{"id":2676942,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":33476,"kind":"person","name":"Alland Leila","position":1,"cik":"0001825216","reported_name":"Alland Leila","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-06-08T23:22:02.000Z","date":"2021-05-12","kind":"grant","acquired":true,"shares":36279,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Shares subject to the option vest in 48 equal monthly installments beginning on June 12, 2021."}],"balance_after":36279,"derivative":{"exercise_price":28.33,"expiration_date":"2031-05-11","underlying":"Common Stock","underlying_shares":36279},"source":{"system":"sec-edgar","filing":"0001209191-21-039035","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1699382/000120919121039035/doc4.xml","form_type":"4"}},{"id":2676941,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":33476,"kind":"person","name":"Alland Leila","position":1,"cik":"0001825216","reported_name":"Alland Leila","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-06-08T23:22:02.000Z","date":"2021-06-07","kind":"sale","acquired":false,"shares":1367,"price":34.0041,"value":46483.6047,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 30, 2020."},{"field":"shares","element":"transactionShares","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.705 to $34.255, inclusive."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-21-039035","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1699382/000120919121039035/doc4.xml","form_type":"4"}},{"id":2676940,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":33476,"kind":"person","name":"Alland Leila","position":1,"cik":"0001825216","reported_name":"Alland Leila","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-06-08T23:22:02.000Z","date":"2021-06-07","kind":"sale","acquired":false,"shares":2633,"price":33.3852,"value":87903.2316,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 30, 2020."},{"field":"shares","element":"transactionShares","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.705 to $33.66, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4."}],"balance_after":1367,"source":{"system":"sec-edgar","filing":"0001209191-21-039035","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1699382/000120919121039035/doc4.xml","form_type":"4"}},{"id":2676939,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":33476,"kind":"person","name":"Alland Leila","position":1,"cik":"0001825216","reported_name":"Alland Leila","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-06-08T23:22:02.000Z","date":"2021-06-07","kind":"exercise","acquired":true,"shares":4000,"price":3.9,"value":15600.0,"ownership":{"direct":true},"balance_after":4000,"source":{"system":"sec-edgar","filing":"0001209191-21-039035","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1699382/000120919121039035/doc4.xml","form_type":"4"}},{"id":2694348,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":33476,"kind":"person","name":"Alland Leila","position":1,"cik":"0001825216","reported_name":"Alland Leila","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-05-28T01:41:45.000Z","date":"2021-05-25","kind":"grant","acquired":true,"shares":98168,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"All of the stock options will vest on November 25, 2021."}],"balance_after":98168,"derivative":{"exercise_price":1.49,"expiration_date":"2031-05-25","underlying":"Common Stock","underlying_shares":98168},"source":{"system":"sec-edgar","filing":"0001493152-21-013114","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315221013114/ownership.xml","form_type":"4"}},{"id":2694347,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":33476,"kind":"person","name":"Alland Leila","position":1,"cik":"0001825216","reported_name":"Alland Leila","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-28T01:41:45.000Z","date":"2021-05-25","kind":"grant","acquired":true,"shares":77181,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"All of the restricted stock will vest on November 25, 2021."}],"balance_after":77181,"source":{"system":"sec-edgar","filing":"0001493152-21-013114","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315221013114/ownership.xml","form_type":"4"}},{"id":2720434,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":33476,"kind":"person","name":"Alland Leila","position":1,"cik":"0001825216","reported_name":"Alland Leila","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-05-10T21:06:48.000Z","date":"2021-05-07","kind":"exercise","acquired":false,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"One-fourth of the shares subject to the option vested on December 3, 2020, and one forty-eighth of the shares subject to the option shall vest each month thereafter."}],"balance_after":369850,"derivative":{"exercise_price":3.9,"expiration_date":"2030-02-04","underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001209191-21-031300","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1699382/000120919121031300/doc4.xml","form_type":"4"}},{"id":2720433,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":33476,"kind":"person","name":"Alland Leila","position":1,"cik":"0001825216","reported_name":"Alland Leila","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-05-10T21:06:48.000Z","date":"2021-05-07","kind":"sale","acquired":false,"shares":158,"price":35.4891,"value":5607.2778,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 30, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.47 to $35.50, inclusive."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-21-031300","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1699382/000120919121031300/doc4.xml","form_type":"4"}},{"id":2720432,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":33476,"kind":"person","name":"Alland Leila","position":1,"cik":"0001825216","reported_name":"Alland Leila","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-05-10T21:06:48.000Z","date":"2021-05-07","kind":"sale","acquired":false,"shares":3842,"price":34.8,"value":133701.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 30, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.30 to $35.11, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4."}],"balance_after":158,"source":{"system":"sec-edgar","filing":"0001209191-21-031300","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1699382/000120919121031300/doc4.xml","form_type":"4"}},{"id":2720431,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":33476,"kind":"person","name":"Alland Leila","position":1,"cik":"0001825216","reported_name":"Alland Leila","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-05-10T21:06:48.000Z","date":"2021-05-07","kind":"exercise","acquired":true,"shares":4000,"price":3.9,"value":15600.0,"ownership":{"direct":true},"balance_after":4000,"source":{"system":"sec-edgar","filing":"0001209191-21-031300","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1699382/000120919121031300/doc4.xml","form_type":"4"}},{"id":2752657,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":33476,"kind":"person","name":"Alland Leila","position":1,"cik":"0001825216","reported_name":"Alland Leila","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-04-08T20:13:31.000Z","date":"2021-04-07","kind":"exercise","acquired":false,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"One-fourth of the shares subject to the option vested on December 3, 2020, and one forty-eighth of the shares subject to the option shall vest each month thereafter."}],"balance_after":373850,"derivative":{"exercise_price":3.9,"expiration_date":"2030-02-04","underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001209191-21-026064","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1699382/000120919121026064/doc4.xml","form_type":"4"}},{"id":2752656,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":33476,"kind":"person","name":"Alland Leila","position":1,"cik":"0001825216","reported_name":"Alland Leila","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-04-08T20:13:31.000Z","date":"2021-04-07","kind":"sale","acquired":false,"shares":28,"price":34.4211,"value":963.7908,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 30, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.37 to $34.50, inclusive."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-21-026064","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1699382/000120919121026064/doc4.xml","form_type":"4"}},{"id":2752655,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":33476,"kind":"person","name":"Alland Leila","position":1,"cik":"0001825216","reported_name":"Alland Leila","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-04-08T20:13:31.000Z","date":"2021-04-07","kind":"sale","acquired":false,"shares":3972,"price":33.8572,"value":134480.7984,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 30, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.33 to $34.24, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4."}],"balance_after":28,"source":{"system":"sec-edgar","filing":"0001209191-21-026064","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1699382/000120919121026064/doc4.xml","form_type":"4"}},{"id":2752654,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":33476,"kind":"person","name":"Alland Leila","position":1,"cik":"0001825216","reported_name":"Alland Leila","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-04-08T20:13:31.000Z","date":"2021-04-07","kind":"exercise","acquired":true,"shares":4000,"price":3.9,"value":15600.0,"ownership":{"direct":true},"balance_after":4000,"source":{"system":"sec-edgar","filing":"0001209191-21-026064","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1699382/000120919121026064/doc4.xml","form_type":"4"}}]}